Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
SOPH Chief Scientific Officer Xu Zhenyu Sells 4,000 Shares
What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 4,000 shares on 2026-06-15 in an open-market transaction. The reported weighted-average sale price was $5.01 per share, for total proceeds of $20,056. This was a sale (S), not a purchase.
Key Details
- Transaction date: 2026-06-15; Form 4 filed: 2026-06-17 (timely filing).
- Price: weighted average $5.01; shares sold in multiple trades at prices ranging $4.90 to $5.13. The filer can provide a per-price breakdown on request.
- Total shares sold: 4,000; total proceeds reported: $20,056.
- Transaction made pursuant to a pre-established Rule 10b5-1(c) trading plan (footnote).
- Shares owned after the transaction: not disclosed in this filing.
Context
Sales executed under a 10b5-1 plan are pre-arranged and often reflect scheduled, routine dispositions rather than a contemporaneous view of the company. For retail investors, purchases typically signal stronger insider conviction than routine sales; this filing documents a modest, planned sale by a company executive.
Insider Transaction Report
Form 4
Xu Zhenyu
Chief Scientific Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-06-15$5.01/sh−4,000$20,056→ 622,280 total
Footnotes (2)
- [F1]Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.90 to $5.13, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Zhenyu Xu|2026-06-17